Kocks, Janwillem http://orcid.org/0000-0002-2760-0693
Ferreira, António Jorge
Bakke, Per
van Schayck, Onno C. P.
Ekroos, Heikki
Tzanakis, Nikolaos
Soulard, Stéphane http://orcid.org/0000-0003-1970-6823
Haaksma-Herczegh, Monika
Mestres-Simon, Montserrat
Águila-Fuentes, Malena http://orcid.org/0000-0002-6654-4516
Cataldo, Didier http://orcid.org/0000-0002-3079-7941
Funding for this research was provided by:
Boehringer Ingelheim
Boehringer Ingelheim
Article History
Received: 13 May 2022
Accepted: 20 February 2023
First Online: 3 May 2023
Competing interests
: This study was supported by Boehringer Ingelheim. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). This study was supported by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. M.H.H. and S.S. are employees of Boehringer Ingelheim. J.K. reports grants, personal fees and non-financial support from AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, GSK, Novartis, MundiPharma and TEVA. P.B. reports lecture fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK and Novartis. O.C.P.v.S. reports grants and fees from Boehringer Ingelheim, Pfizer and Chiesi. D.C., founder of Aquilon Pharmaceuticals, received fees from AstraZeneca, Boehringer Ingelheim, Chiesi and GSK. H.E. receives fees from AstraZeneca, Boehringer Ingelheim and GSK. A.J.F. has received speaker fees from Bial, GSK, Teva, Mylan, Menarini.